| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
PRAX
Praxis Precision Medicines
|
Jun 02, 2026 | BUY |
Strong Buy
+92.1% avg upside
24 analysts
|
$400.00
41.63% Upside
|
+4.6% |
|
ANRO
Alto Neuroscience, Inc.
|
May 18, 2026 | BUY |
Strong Buy
+33.3% avg upside
13 analysts
|
$36.00
58.37% Upside
|
-2.9% |
|
MIRM
Mirum Pharmaceuticals
|
May 07, 2026 | BUY |
Strong Buy
+7.5% avg upside
21 analysts
|
$129.00
20.45% Upside
|
+4.1% |
|
JAZZ
Jazz Pharmaceuticals
|
May 06, 2026 | BUY |
Strong Buy
-1.8% avg upside
35 analysts
|
$252.00
12.10% Upside
|
+0.9% |
|
AXSM
Axsome Therapeutics
|
May 05, 2026 | BUY |
Strong Buy
-10.6% avg upside
28 analysts
|
$246.00
1.70% Downside
|
+12.9% |
|
XENE
Xenon
|
Mar 09, 2026 | BUY |
Strong Buy
+19.0% avg upside
28 analysts
|
$97.00
83.35% Upside
|
-16.5% |
|
SRPT
Sarepta Therapeutics
|
Feb 26, 2026 | HOLD |
Buy
+246.5% avg upside
49 analysts
|
$20.00
14.17% Upside
|
-9.7% |
|
GILD
Gilead Sciences
|
Feb 11, 2026 | HOLD |
Strong Buy
-4.8% avg upside
66 analysts
|
$145.00
17.26% Upside
|
-19.6% |
|
RGNX
RegenXBio
|
Feb 10, 2026 | BUY |
Strong Buy
+381.2% avg upside
22 analysts
|
$27.00
246.18% Upside
|
-35.4% |
|
REGN
Regeneron
|
Feb 02, 2026 | HOLD |
Strong Buy
+26.9% avg upside
57 analysts
|
$742.00
21.69% Upside
|
-18.4% |
|
BIIB
Biogen
|
Oct 31, 2025 | BUY |
Strong Buy
+25.1% avg upside
51 analysts
|
$250.00
27.14% Upside
|
+28.8% |
|
CRNX
Crinetics Pharmaceuticals
|
Sep 26, 2025 | BUY |
Strong Buy
+121.2% avg upside
20 analysts
|
$62.00
72.94% Upside
|
-27.5% |
|
BHVN
Biohaven Ltd.
|
Aug 12, 2025 | BUY |
Strong Buy
+87.5% avg upside
25 analysts
|
$52.00
283.14% Upside
|
+0.7% |
|
NBIX
Neurocrine
|
Jul 31, 2025 | BUY |
Strong Buy
+7.8% avg upside
37 analysts
|
$186.00
17.42% Upside
|
+24.6% |
|
DYN
Dyne Therapeutics
|
Jun 18, 2025 | BUY |
Strong Buy
+93.5% avg upside
29 analysts
|
$32.00
61.56% Upside
|
+73.8% |
|
ALMS
Alumis Inc.
|
Feb 07, 2025 | BUY |
Strong Buy
+63.6% avg upside
11 analysts
|
$17.00
27.36% Downside
|
+361.9% |
|
VRTX
Vertex Pharmaceuticals
|
Jan 31, 2025 | SELL |
Strong Buy
-2.7% avg upside
61 analysts
|
$320.00
29.11% Downside
|
-1.8% |
|
BNTC
Benitec Biopharma
|
Dec 12, 2024 | BUY |
Strong Buy
+118.9% avg upside
13 analysts
|
$30.00
146.98% Upside
|
-3.0% |
|
ENTA
Enanta Pharmaceuticals
|
Nov 26, 2024 | BUY |
Buy
+159.2% avg upside
17 analysts
|
$20.00
58.05% Upside
|
+62.8% |
|
LXEO
Lexeo Therapeutics, Inc.
|
Nov 20, 2024 | BUY |
Strong Buy
+313.4% avg upside
11 analysts
|
$28.00
468.01% Upside
|
+45.6% |
|
ABUS
Arbutus Biopharma
|
Nov 06, 2024 | HOLD |
Strong Buy
+94.1% avg upside
15 analysts
|
$4.00
12.17% Downside
|
+13.3% |
|
AMGN
Amgen
|
Sep 24, 2024 | SELL |
Buy
-11.6% avg upside
57 analysts
|
$215.00
36.29% Downside
|
+12.8% |
|
NRIX
Nurix Therapeutics
|
Sep 05, 2024 | BUY |
Strong Buy
+76.3% avg upside
26 analysts
|
$26.00
48.06% Upside
|
-59.5% |
|
OKUR
OnKure Therapeutics
|
Dec 14, 2023 | HOLD |
Buy
+428.3% avg upside
12 analysts
|
$30.00
569.74% Upside
|
-26.4% |
|
CUE
Cue Biopharma
|
Nov 10, 2022 | BUY |
Strong Buy
-66.0% avg upside
9 analysts
|
$28.00
1.62% Downside
|
-26.0% |
|
VTGN
VistaGen Therapeutics
|
Nov 10, 2022 | HOLD |
Hold
+287.9% avg upside
8 analysts
|
$7.50
1019.11% Upside
|
-34.1% |
|
TBPH
Theravance Biopharma
|
Nov 07, 2022 | HOLD |
Buy
+12.2% avg upside
18 analysts
|
$8.00
51.68% Downside
|
-3.2% |
|
IMVT
Immunovant
|
Sep 08, 2022 | HOLD |
Strong Buy
+9.0% avg upside
24 analysts
|
$6.00
82.97% Downside
|
+359.1% |
|
ASMB
Assembly Biosciences
|
Mar 31, 2022 | BUY |
Strong Buy
+38.6% avg upside
10 analysts
|
$15.00
38.70% Downside
|
-59.2% |
|
TIL
Instil Bio
|
Aug 12, 2021 | BUY |
Buy
+343.4% avg upside
8 analysts
|
$34.00
353.35% Upside
|
-57.8% |
|
QTTB
Q32 Bio
|
Aug 12, 2021 | BUY |
Buy
+345.2% avg upside
24 analysts
|
$16.00
34.36% Upside
|
-59.7% |
|
CLLS
Cellectis SA
|
Aug 06, 2021 | BUY |
Strong Buy
+569.9% avg upside
16 analysts
|
$39.00
1208.74% Upside
|
-75.8% |
|
NTLA
Intellia Therapeutics
|
Aug 05, 2021 | HOLD |
Buy
+153.7% avg upside
37 analysts
|
$146.00
831.62% Upside
|
-61.7% |
|
VYGR
Voyager Therapeutics
|
May 10, 2021 | HOLD |
Strong Buy
+284.7% avg upside
23 analysts
|
$6.00
61.21% Upside
|
+47.2% |
|
CRIS
Curis
|
Nov 01, 2018 | BUY |
Strong Buy
+1938.0% avg upside
12 analysts
|
$3.00
612.49% Upside
|
+25.1% |
|
ANAB
AnaptysBio
|
Mar 27, 2018 | BUY |
Strong Buy
+26.1% avg upside
26 analysts
|
$144.00
150.38% Upside
|
-37.4% |
|
ONC
BeOne Medicines
|
Feb 28, 2018 | HOLD |
Strong Buy
+28.6% avg upside
28 analysts
|
$138.00
48.85% Downside
|
-4.5% |
|
INSM
Insmed
|
Jan 04, 2018 | BUY |
Strong Buy
+82.1% avg upside
36 analysts
|
$42.00
56.11% Downside
|
-51.2% |
|
BMRN
BioMarin Pharmaceutical
|
Oct 03, 2017 | BUY |
Strong Buy
+72.7% avg upside
52 analysts
|
$115.00
110.36% Upside
|
+6.9% |
|
INVA
Innoviva
|
Jul 26, 2017 | HOLD |
Buy
+27.2% avg upside
12 analysts
|
$13.00
42.12% Downside
|
+4.7% |
|
NERV
Minerva Neurosciences
|
Jan 22, 2015 | BUY |
Buy
+68.3% avg upside
8 analysts
|
$11.00
146.11% Upside
|
+3.7% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.